ABE1392 Sigma-AldrichAnti-phospho SIRT1 (Ser682) Antibody
Anti-phospho SIRT1 (Ser682) Antibody, Cat. No. ABE1392, is a highly specific rabbit Polyclonal antibody, that targets SIRT1 and has been tested in Western Blotting.
More>> Anti-phospho SIRT1 (Ser682) Antibody, Cat. No. ABE1392, is a highly specific rabbit Polyclonal antibody, that targets SIRT1 and has been tested in Western Blotting. Less<<Productos recomendados
Descripción
| Replacement Information |
|---|
Tabla espec. clave
| Species Reactivity | Key Applications | Host | Format | Antibody Type |
|---|---|---|---|---|
| H | WB | Rb | Affinity Purified | Polyclonal Antibody |
| References |
|---|
| Product Information | |
|---|---|
| Format | Affinity Purified |
| Presentation | Purified rabbit polyclonal antibody in buffer containing 0.1 M Tris-Glycine (pH 7.4), 150 mM NaCl with 0.05% sodium azide. |
| Quality Level | MQ100 |
| Physicochemical Information |
|---|
| Dimensions |
|---|
| Materials Information |
|---|
| Toxicological Information |
|---|
| Safety Information according to GHS |
|---|
| Safety Information |
|---|
| Storage and Shipping Information | |
|---|---|
| Storage Conditions | Stable for 1 year at 2-8°C from date of receipt. |
| Packaging Information | |
|---|---|
| Material Size | 100 μg |
| Transport Information |
|---|
| Supplemental Information |
|---|
| Specifications |
|---|
| Global Trade Item Number | |
|---|---|
| Número de referencia | GTIN |
| ABE1392 | 04055977176452 |
Documentation
Anti-phospho SIRT1 (Ser682) Antibody Ficha datos de seguridad (MSDS)
| Título |
|---|
Anti-phospho SIRT1 (Ser682) Antibody Certificados de análisis
| Cargo | Número de lote |
|---|---|
| Anti-phospho SIRT1 (Ser682) - 3425415 | 3425415 |
| Anti-phospho SIRT1 (Ser682) - 4158032 | 4158032 |
| Anti-phospho SIRT1 (Ser682) -Q2581259 | Q2581259 |
Licencias necesarias e Información técnica
| Cargo |
|---|
| Characterization of Estrogen Receptor α Phosphorylation Sites in Breast Cancer Tissue Using the SNAP i.d® 2.0 System |
| White Paper: Further considerations of antibody validation and usage. |



